First US Patient Receives New Vercise Genus Deep Brain Stimulation Device

Surgeons in Detroit have become the first U.S. team to implant the newest deep brain stimulation (DBS) system — Boston Scientific’s Vercise Genus — in a Parkinson’s disease patient. The device, smaller and thinner than previous models, aims to reduce movement symptoms associated with Parkinson’s by stimulating…

Vercise Genus, 4th-generation DBS Treatment, Coming Soon to US

Vercise Genus, a fourth-generation system for deep brain stimulation (DBS) to treat people with Parkinson’s disease, is now available in the U.S.,  Boston Scientific, which markets the system, announced. The U.S. Food and Drug Administration approved the system’s conditional use with full-body MRI scans, following a similar…

4th-generation DBS System, Vercise Genus, Available in Europe

Vercise Genus, a fourth-generation system for deep brain stimulation (DBS) made by Boston Scientific, has received CE marking and is now commercially available in Europe. A treatment approach for Parkinson’s disease, DBS involves surgically implanting a neurostimulator to deliver electrical impulses to targeted regions of…